Clinical Trial Update: Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing weekly cetuximab with radiotherapy versus weekly cisplatin with radiotherapy in HPV-positive oropharyngeal squamous cell carcinoma; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-positive Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)

Snippet

Sponsor: Trans Tasman Radiation Oncology Group | Conditions: HPV Positive Oropharyngeal Squamous Cell Carcinoma | Phase 3 | Status: UNKNOWN